RMTI - Rockwell Medical, Inc. (DE) Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Rockwell Medical, Inc. (DE) Common Stock
Rockwell Medical Inc is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, secondary hyperparathyroidism, and hemodialysis.
IPO Date: February 1, 1998
Sector: Healthcare
Industry: Health Care Equipment and Supplies
Market Cap: $33.13M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.16 | 3.32%
Avg Daily Range (30 D): $0.22 | 2.78%
Avg Daily Range (90 D): $0.17 | 3.06%
Institutional Daily Volume
Avg Daily Volume: .38M
Avg Daily Volume (30 D): .02M
Avg Daily Volume (90 D): .1M
Trade Size
Avg Trade Size (Sh.): 267
Avg Trade Size (Sh.) (30 D): 90
Avg Trade Size (Sh.) (90 D): 237
Institutional Trades
Total Institutional Trades: 185
Avg Institutional Trade: $1.17M
Avg Institutional Trade (30 D): $M
Avg Institutional Trade (90 D): $M
Avg Institutional Trade Volume: M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.46M
Avg Closing Trade (30 D): $M
Avg Closing Trade (90 D): $M
Avg Closing Volume: 3.07K
 
News
Aug 14, 2025 @ 10:21 AM
Rockwell Medical Tops Q2 EPS View
Source: Jesterai
Oct 9, 2024 @ 8:12 PM
DaVita Stock Gains 47.3% Year to Date: What's Behi...
Source: Zacks, Benzinga Contributor
May 14, 2024 @ 11:15 AM
Rockwell Medical (RMTI) Reports Q1 Loss, Tops Reve...
Source: Zacks Equity Research
Mar 26, 2024 @ 10:15 PM
Rockwell Medical (RMTI) Increases Despite Market S...
Source: Zacks Equity Research
Mar 21, 2024 @ 11:10 AM
Rockwell Medical (RMTI) Q4 Earnings and Revenues B...
Source: Zacks Equity Research
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-.8 $-.34 $-.04
Diluted EPS $-.8 $-.7 $-.04
Revenue $69.39M $17.78M $17.34M
Gross Profit $12.29M $3.24M $2.9M
Net Income / Loss $-5.08M $-1.17M $-1.61M
Operating Income / Loss $-4.52M $-1.06M $-1.48M
Cost of Revenue $57.1M $14.54M $14.44M
Net Cash Flow $-1.96M $.91M $-1.1M
PE Ratio    
Splits
Jul 01, 2026 1:10
May 13, 2022 1:11